Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cardocalm
- Development stage
- Unknown
- Lead developer
- Vaidyaratnam Oushadhasala
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Cardocalm is a proprietary polyherbal Ayurvedic formulation manufactured by Vaidyaratnam Oushadhasala. It is primarily indicated for the management of hypertension and the support of cardiovascular health. Drawing on the classical Ashtavaidya tradition of Kerala, Cardocalm combines several potent herbs, including Sarpagandha (*Rauvolfia serpentina*), Arjuna (*Terminalia arjuna*), Punarnava (*Boerhavia diffusa*), Nimba (*Azadirachta indica*), and Triphala (a blend of Amalaki, Bibhitaki, and Haritaki). These ingredients work synergistically to regulate blood pressure, strengthen the myocardium, promote diuresis, reduce stress and anxiety, and provide antioxidant protection.
- Brand names
- Cardocalm
- Other names
- Cardocalm Tablets
02
Targets
VMAT1 (Vesicular monoamine transporter type 1)AMPK (Adenosine monophosphate–activated protein kinase)VMAT2 (Vesicular monoamine transporter 2)GABRR (GABA-A receptor subunit rho)
Beyond the preview
Go deeper on Cardocalm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cardocalm.